α-Synuclein 4554W

α-Synuclein 4554W, previously identified through intracellular library screening, is an inhibitor of α-Synuclein (aSyn) aggregation and its associated toxicity. This compound, comprising GIVNGVKA sequences, effectively reduces fibril formation in aSyn mutants associated with Parkinson's disease [1].

[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)C)=O)CCCCN)=O)[C@H](C)C)=O)=O)CC(N)=O)=O)[C@H](C)C)=O)(NC(CNC([C@@H](NC([C@H](CCCCN)NC(C)=O)=O)CC(O)=O)=O)=O)[C@H](CC)C